模拟T细胞对癌症免疫疗法的时间反应,合理化了组合治疗方案的开发
Oren Barboy1, Akhiad Bercovich2, Hanjie Li3
1Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Nature cancer
|March 1, 2024
概括
追踪瘤特异性CD8+ T细胞揭示了两种抗PD-1活性模式. 将抗PD-1与抗-4-1BB治疗结合起来,可以促进T细胞的招募和扩散,以控制瘤.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
- 系统生物学 系统生物学
背景情况:
- 免疫治疗的有效性取决于瘤和外围的复杂T细胞动态.
- 目前的方法,如静态单细胞地图和小鼠模型,限制了这些动态反应的详细表征.
- 了解T细胞随着时间的推移的行为对于优化癌症治疗至关重要.
研究的目的:
- 开发一个框架,以随着时间的推移来追踪瘤特异性CD8+ T细胞在单细胞分辨率的体内追踪.
- 在瘤微环境 (TME) 和瘤排水淋巴结 (tdLN) 中建模基因程序动态.
- 描述反编程细胞死亡蛋白1 (PD-1) 活动的不同模式及其对T细胞反应的影响.
主要方法:
- 开发了一种用于瘤特异性CD8+T细胞的纵向单细胞分辨率体内追踪的新框架.
- 利用这个框架在TME和tdLN中建模基因表达动态.
- 分析了T细胞分化,增殖和招募模式,以应对免疫疗法.
主要成果:
- 描述了两种不同的抗PD-1疗法活性模式,将T细胞分化与增殖和招募分开.
- 证明抗PD-1疗法的有效性与激活前体CD8+ T细胞涌入TME有关.
- 显示,将抗PD-1与抗-4-1BB激动剂结合起来,可显著增强激活前体的招募和扩散,从而控制瘤.
结论:
- 有效的抗PD-1免疫疗法需要激活前体CD8+ T细胞足够的透到瘤微环境中.
- 将抗PD-1与抗-4-1BB激素治疗结合起来,代表了增强T细胞反应和实现瘤控制的有希望的策略.
- 了解T细胞反应的系统级动态对于合理设计和优化免疫疗法至关重要.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
T Cell Activation and Clonal Selection
731
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
731


